Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
IC – 171.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Marta Duda-Sikuła

Marta Duda-Sikuła, PhD, is a psychologist and medical scientist with extensive expertise in
clinical research, particularly at the intersection of medicine, psychology, and clinical trial
operations. With over a decade of experience in managing complex, multidisciplinary clinical
studies, she is deeply committed to patient-centered approaches that enhance both research
quality and care outcomes.
Dr. Duda-Sikuła has been actively involved in numerous international research initiatives
focused on neurological and rare diseases, including projects under Horizon 2020, the Joint
Programme – Neurodegenerative Disease Research (JPND), and the European Joint
Programme on Rare Diseases (EJP RD). Her work emphasizes both clinical and psychosocial
aspects of conditions such as autoimmune encephalitis, highlighting the importance of
cognitive and emotional outcomes in the recovery process.
A core aspect of her research involves integrating qualitative psychological methodologies
into clinical trial design and implementation. This approach enhances the understanding of
patient experiences and supports the development of more effective, responsive models of
care.
Dedicated to interdisciplinary collaboration, Dr. Duda-Sikuła combines clinical expertise with
strategic project leadership to drive innovation in neurological and psychiatric healthcare. Her
contributions advance scientific knowledge and inform best practices in patient support for
complex conditions, including autoimmune encephalitis and related disorders.